Structural model of the Plasmodium CDK, Pfmrk, a novel target for malaria therapeutics

Journal of Molecular Graphics and Modelling

Volumn 24, Issue 1, 2005, Pages 72-80

  Peng, Youyi ^a   Keenan, Susan M ^a   Welsh, William J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

CDK; Homology modelling; Ligand docking; Oxindoles; Pfmrk; Plasmodium falciparum; Structural model

Indexed keywords

CLONING; ENZYMES; GENES; MATHEMATICAL MODELS; MEDICAL IMAGING; QUANTUM THEORY;

CDK; HOMOLOGY MODELING; LIGAND DOCKING; OXINDOLES; PFMRK; PLASMODIUM FALCIPARUM; STRUCTURAL MODEL;

MALARIA CONTROL;

ANTIMALARIAL AGENT; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; ENZYME INHIBITOR; MAGNESIUM ION; OXINDOLE;

AB INITIO CALCULATION; ACCURACY; ARTICLE; BINDING AFFINITY; DRUG PROTEIN BINDING; DRUG TARGETING; GENE SEQUENCE; MALARIA; MAMMAL; MODEL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; QUANTUM CHEMISTRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIMALARIALS; CYCLIN-DEPENDENT KINASES; INDOLES; MAGNESIUM; MALARIA, FALCIPARUM; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHENOLS; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTEIN KINASES; PROTOZOAN PROTEINS; SEQUENCE ANALYSIS, PROTEIN;

MAMMALIA; PLASMODIUM FALCIPARUM;

EID: 24944573556     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2005.06.002     Document Type: Article

References (54)

1. J.G. Breman The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden Am. J. Trop. Med. Hyg. 64 2001 1 11
2. N.S. Gray, L. Wodicka, A.M. Thunnissen, T.C. Norman, S. Kwon, F.H. Espinoza, D.O. Morgan, G. Barnes, S. LeClerc, L. Meijer, S.H. Kim, D.J. Lockhart, and P.G. Schultz Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors Science 281 1998 533 538
3. P.B. Bloland, E.M. Lackritz, P.N. Kazembe, J.B. Were, R. Steketee, and C.C. Campbell Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa J. Infect. Dis. 167 1993 932 937
4. J. Sachs, and P. Malaney The economic and social burden of malaria Nature 415 2002 680 685
5. A. Naderi, A.A. Ahmed, N.L. Barbosa-Morais, S. Aparicio, J.D. Brenton, and C. Caldas Expression microarray reproducibility is improved by optimising purification steps in RNA amplification and labelling BMC Genomics 5 2004 9
6. P.B. Ross-Macdonald, R. Graeser, B. Kappes, R. Franklin, and D.H. Williamson Isolation and expression of a gene specifying a cdc2-like protein kinase from the human malaria parasite Plasmodium falciparum Eur. J. Biochem. 220 1994 693 701
7. V. Bracchi-Ricard, S. Barik, C. Delvecchio, C. Doerig, R. Chakrabarti, and D. Chakrabarti PfPK6, a novel cyclin-dependent kinase/mitogen-activated protein kinase-related protein kinase from Plasmodium falciparum Biochem. J. 347 Pt 1 2000 255 263
8. C. Doerig, J. Endicott, and D. Chakrabarti Cyclin-dependent kinase homologues of Plasmodium falciparum Int. J. Parasitol. 32 2002 1575 1585
9. J.L. Li, K.J. Robson, J.L. Chen, G.A. Targett, and D.A. Baker Pfmrk, a MO15-related protein kinase from Plasmodium falciparum. Gene cloning, sequence, stage-specific expression and chromosome localization Eur. J. Biochem. 241 1996 805 813
10. S. Zhai, A.M. Senderowicz, E.A. Sausville, and W.D. Figg Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development Ann. Pharmacother. 36 2002 905 911
11. S.H. Chao, and D.H. Price Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo J. Biol. Chem. 276 2001 31793 31799
12. S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J.A. Bibb, G.L. Snyder, P. Greengard, J. Biernat, Y.Z. Wu, E.M. Mandelkow, G. Eisenbrand, and L. Meijer Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276 2001 251 260
13. A.M. Senderowicz, and E.A. Sausville Preclinical and clinical development of cyclin-dependent kinase modulators J. Natl. Cancer Inst. 92 2000 376 387
14. L. Meijer, and E. Raymond Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials Acc. Chem. Res. 36 2003 417 425
15. N.C. Waters, and J.A. Geyer Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development Expert Opin. Ther. Targets 7 2003 7 17
16. C. Doerig Protein kinases as targets for anti-parasitic chemotherapy Biochim. Biophys. Acta 1697 2004 155 168
17. N.C. Waters, C.L. Woodard, and S.T. Prigge Cyclin H activation and drug susceptibility of the Pfmrk cyclin dependent protein kinase from Plasmodium falciparum Mol. Biochem. Parasitol. 107 2000 45 55
18. Z. Li, K. Le Roch, J.A. Geyer, C.L. Woodard, S.T. Prigge, J. Koh, C. Doerig, and N.C. Waters Influence of human p16(INK4) and p21(CIP1) on the in vitro activity of recombinant Plasmodium falciparum cyclin-dependent protein kinases Biochem. Biophys. Res. Commun. 288 2001 1207 1211
19. K. Le Roch, C. Sestier, D. Dorin, N. Waters, B. Kappes, D. Chakrabarti, L. Meijer, and C. Doerig Activation of a Plasmodium falciparum cdc2-related kinase by heterologous p25 and cyclin H. Functional characterization of a P. falciparum cyclin homologue J. Biol. Chem. 275 2000 8952 8958
20. Z. Guo, and J.W. Stiller Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs BMC Genomics 5 2004 69
21. P. Ward, L. Equinet, J. Packer, and C. Doerig Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote BMC Genomics 5 2004 79
22. J. Shuttleworth The regulation and functions of cdk7 Progr. Cell Cycle Res. 1 1995 229 240
23. H. Serizawa, T.P. Makela, J.W. Conaway, R.C. Conaway, R.A. Weinberg, and R.A. Young Association of Cdk-activating kinase subunits with transcription factor TFIIH Nature 374 1995 280 282
24. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucl. Acids Res. 22 1994 4673 4680
25. R. Lopez, S. Programme, A. Loyd, ClustalW WWW service at the European Bioinformatics Institute, http://www.ebi.ac.uk/clustalw
26. B. Rost, and C. Sander Prediction of protein secondary structure at better than 70% accuracy J. Mol. Biol. 232 1993 584 599
27. J. Park, S.A. Teichmann, T. Hubbard, and C. Chothia Intermediate sequences increase the detection of homology between sequences J. Mol. Biol. 273 1997 349 354
28. D.T. Jones Protein secondary structure prediction based on position-specific scoring matrices J. Mol. Biol. 292 1999 195 202
29. G.P.S. Raghava Protein secondary structure prediction using nearest neighbor and neural network approach CASP 4 2000 75 76
30. P. Baldi, S. Brunak, P. Frasconi, G. Soda, and G. Pollastri Exploiting the past and the future in protein secondary structure prediction Bioinformatics 15 1999 937 946
31. K. Karplus, C. Barrett, and R. Hughey Hidden Markov models for detecting remote protein homologies Bioinformatics 14 1998 846 856
32. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucl. Acids Res. 25 1997 3389 3402
33. N.R. Brown, M.E. Noble, J.A. Endicott, and L.N. Johnson The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases Nat. Cell Biol. 1 1999 438 443
34. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The Protein Data Bank Nucl. Acids Res. 28 2000 235 242
35. G. Vriend, WHAT IF: a molecular modeling and drug design program, J. Mol. Graph 8 (1990) 52-56.
36. InsightII 2000: Accelrys Inc., San Diego, CA.
37. A. Cavalli, C. Dezi, G. Folkers, L. Scapozza, and M. Recanatini Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKs Proteins 45 2001 478 485
38. M.J. Frisch, G.W Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, Jr., T. Vreven, K.N. Kudin, J.C. Burant, J. M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople Gaussian98, Gaussian, Inc., Pittsburgh PA 1998
39. C.I. Bayly, P. Cieplak, W. Cornell, and P.A. Kollman A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model J. Phys. Chem. 97 1993 10269 10280
40. J.P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen Numerical integration of Cartesian equation of motion of a system with constraints:molecular dynamics of N-alkanes J. Comput. Phys. 23 1977 327 341
41. H.J.C. Berendsen, J.P.M. Postm, W.F. Van Gunsteren, A. Di Nola, and J.R. Haak Molecular dynamics with coupling to an external bath J. Chem. Phys. 81 1984 3684 3690
42. L. Banci, S. Schroder, and P.A. Kollman Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitors adducts Proteins 4 1992 288 305
43. A.L. Morris, M.W. MacArthur, E.G. Hutchinson, and J.M. Thornton Stereochemical quality of protein structure coordinates Proteins 12 1992 345 364
44. R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Cryst. 26 1993 283 291
45. N.C. Waters, Personal communication, 2003.
46. C.L. Woodard, Z. Li, A.K. Kathcart, J. Terrell, L. Gerena, M. Lopez-Sanchez, D.E. Kyle, A.K. Bhattacharjee, D.A. Nichols, W. Ellis, S.T. Prigge, J.A. Geyer, and N.C. Waters Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases J. Med. Chem. 46 2003 3877 3882
47. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R. Taylor Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267 1997 727 748
48. Sybyl 6.8: Tripos, Inc.: St. Louis, MO.
49. DSviewerPro 5.0: Accelrys Inc., San Diego, CA.
50. S. Holton, A. Merckx, D. Burgess, C. Doerig, M. Noble, and J. Endicott Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition Structure 11 2003 1329 1337
51. G. Lolli, E.D. Lowe, N.R. Brown, and L.N. Johnson The crystal structure of human CDK7 and its protein recognition properties Structure 12 2004 2067 2079
52. M.L. Verdonk, J.C. Cole, M.J. Hartshorn, C.W. Murray, and R.D. Taylor Improved protein-ligand docking using GOLD Proteins 52 2003 609 623
53. J.W. Nissink, C. Murray, M. Hartshorn, M.L. Verdonk, J.C. Cole, and R. Taylor A new test set for validating predictions of protein-ligand interaction Proteins 49 2002 457 471
54. M. Kontoyianni, L.M. McClellan, and G.S. Sokol Evaluation of docking performance: comparative data on docking algorithms J. Med. Chem. 47 2004 558 565